TANGO THERAPEUTICS INC (TNGX)
US87583X1090 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -123.40M | -101.74M | -108.18M | -58.24M | -120.00K | |||
| Depreciation Amortization | 2.49M | 2.42M | 1.61M | 900.00K | N/A | |||
| Change In Working Capital | -25.34M | -37.97M | -18.49M | -11.35M | -140.00K | |||
| Other non cash items | 23.93M | 19.31M | 15.98M | 9.16M | -70.00K | |||
| OPERATING CASH FLOW | -122.32M | -117.98M | -109.08M | -59.53M | -330.00K | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -856.00K | -1.53M | -7.69M | -1.84M | N/A | |||
| Other Investing Activity | 68.78M | 42.95M | 34.09M | -181.60M | -166.75M | |||
| INVESTING CASH FLOW | 67.92M | 41.43M | 26.40M | -183.43M | -166.75M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 47.53M | 81.96M | 1.62M | 31.05M | 172.11M | |||
| Other Financing Activity | N/A | 448.00K | -10.00K | 326.28M | -3.72M | |||
| FINANCING CASH FLOW | 48.16M | 82.41M | 1.62M | 357.33M | 168.39M | |||
| CHANGE IN CASH | -6.23M | 5.85M | -81.06M | 114.37M | 1.31M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -122.32M | -117.98M | -109.08M | -59.53M | -330.00K | |||
| Capital Expenditure | -856.00K | -1.53M | -7.69M | -1.84M | N/A | |||
| FREE CASH FLOW | -123.17M | -119.51M | -116.77M | -61.37M | -330.00K | |||
All data in USD